Gestational Trophoblastic Disease
Key Points
- Gestational trophoblastic disease (GTD) is a rare trophoblast-origin tumor spectrum that develops during pregnancy.
- The most common GTD type is hydatidiform mole (molar pregnancy), classified as complete or partial.
- Diagnosis commonly uses pelvic ultrasound plus markedly elevated serum hCG.
- Initial management is usually uterine evacuation (dilation and curettage), followed by serial hCG surveillance for persistent disease.
Pathophysiology
GTD develops when trophoblast cells grow abnormally and form neoplastic placental tissue rather than a viable pregnancy. Hydatidiform moles are the most common form.
In complete molar pregnancy, sperm fertilizes an empty ovum, resulting in abnormal placental proliferation without fetal development. In partial molar pregnancy, two sperm fertilize one ovum, producing an abnormal nonviable embryo with excess chromosomal material plus abnormal placental tissue.
While a hydatidiform mole is typically confined to the uterus, GTD progression can include gestational trophoblastic neoplasia, including choriocarcinoma risk patterns.
Classification
- Complete mole: No viable fetal tissue, diffuse abnormal trophoblastic/placental growth.
- Partial mole: Nonviable fetal tissue may be present with abnormal placental tissue.
- Postmolar persistent disease risk: Persistent/rising hCG after treatment suggests GTN progression.
Nursing Assessment
NCLEX Focus
Prioritize bleeding/hemodynamic safety and strict posttreatment hCG trend follow-up.
- Assess presenting symptoms: vaginal bleeding, pelvic pain, severe nausea/vomiting, hypertension features, and coagulopathy indicators.
- Support diagnostic workup readiness (pelvic ultrasound and quantitative serum hCG trends).
- After treatment, monitor serial hCG trends and escalate persistent or rising values.
- Assess emotional response to pregnancy loss and future-fertility anxiety.
Nursing Interventions
- Coordinate timely procedural treatment planning (typically dilation and curettage).
- Reinforce fertility-goal informed counseling, including hysterectomy discussion when future fertility is not desired.
- Support prophylactic antineoplastic medication plans when ordered (for example methotrexate or actinomycin-D).
- Teach the importance of posttreatment follow-up visits and serial hCG surveillance.
- Provide emotional support for the patient and partner, and facilitate counseling/support resources.
- Reinforce referral recommendations such as genetic counseling due to recurrence risk concerns.
hCG Surveillance Safety
Persistent or rising hCG after treatment may indicate persistent GTD or progression to GTN (including choriocarcinoma) and requires urgent specialist reassessment.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| antineoplastic-agents | Methotrexate, actinomycin-D | May be prescribed prophylactically to reduce postmolar GTN risk; monitor adherence and adverse effects per protocol. |
Clinical Judgment Application
Clinical Scenario
A patient treated with dilation and curettage for molar pregnancy returns for follow-up and reports ongoing anxiety; current hCG trend has plateaued rather than declining.
- Recognize Cues: Posttreatment hCG is not falling as expected and psychosocial distress is high.
- Analyze Cues: Pattern raises concern for persistent trophoblastic disease requiring rapid reassessment.
- Prioritize Hypotheses: Highest priority is detection of GTN progression while supporting emotional stabilization.
- Generate Solutions: Coordinate urgent specialty review, repeat hCG testing plan, and reinforce follow-up adherence.
- Take Action: Escalate to provider pathway and provide structured education/support resources.
- Evaluate Outcomes: hCG trajectory is clarified promptly and patient receives ongoing clinical and emotional support.
Related Concepts
- conditions-limited-to-pregnancy - GTD is a high-risk condition unique to pregnancy physiology.
- pregnancy-loss - Molar pregnancy is a pregnancy-loss experience requiring integrated bereavement support.
- malignant-reproductive-neoplasms - GTN/choriocarcinoma progression risk requires oncology-linked vigilance.
- preconceptual-care - Future-pregnancy planning benefits from recurrence-risk counseling and follow-up optimization.
Self-Check
- How do complete and partial molar pregnancies differ clinically and genetically?
- Why is serial hCG follow-up essential after molar-pregnancy treatment?
- Which findings after treatment should prompt urgent reassessment for persistent GTD?